ProBiotix Health will be exhibiting its flagship probiotic strain LPLDL (Lactobacillus plantarum) and new menopause support solutions, YourBiotixMH and YourBiotixPMH, at SupplySide Global 2025.
The event, being held on October 29-30 in Las Vegas, marks ProBiotix Health’s entry into the US women’s health market.
YourBiotixMH and YourBiotixPMH were formulated to reshape the conversation around menopause.
Visitors to the ProBiotix Health stand at #7853 can explore the benefits of these formulations and discover how they not only address day-to-day symptom relief but also the long-term health risks for women in the menopause cohort.
Steen Andersen, Chief Operating Officer at ProBiotix Health, said: "Menopause is a natural stage of life for most women, yet its impact extends far beyond hot flushes or sleep disturbances."
"The decline in oestrogen during menopause profoundly impacts women’s health, increasing risks of high cholesterol, hypertension, arterial stiffness and loss of bone density."
Cardiovascular disease remains the leading cause of death among American women, with post-menopausal women five times more likely to suffer a heart attack, whilst 77% of women aged 45+ have raised cholesterol.
Unlike conventional supplements that focus mainly on vasomotor symptoms, YourBiotixMH and YourBiotixPMH harness the power of LPLDL, ProBiotix Health’s clinically validated probiotic strain.
Formulated in combination with selected nutrients, including Isoflavones, Thiamine, Vitamin D and Vitamin B6, these two products support positive menopausal outcomes.
Andersen added: "These are the first probiotic-based solutions that offer a dual function: relieving and addressing the long-term cardiovascular, physiological and bone health risks that accompany menopause, effectively enabling consumers to add life to years, not just years to life."
The power of YourBiotixMH in transforming women’s health has gained acclaim throughout the nutraceutical industry.
YourBiotixMH was recently named as a finalist in the prestigious NutraIngredients Asia Women’s Health Innovation Award and shortlisted for a WholeFoods Women’s Health Award, further cementing its recognition as a breakthrough product.
Alongside YourBiotixMH and PMH, ProBiotix will also showcase LPLDL at SupplySide Global in finished formulations available for white label, highlighting its proven clinical benefits for cardiometabolic health.
"We believe menopause is more than just a phase and declining oestrogen is more than discomfort — it’s a turning point in a woman’s cardiovascular health," Andersen concluded.
"With YourBiotixMH and YourBiotixPMH, we offer more than just relief, but also a way to protect women’s health well into the future."